Related Experiment Videos
A case of hepatitis C-associated osteosclerosis in an elderly Japanese man
Tokuji Tanaka1, Shogo Oki, Seiji Muro
1Division of Endocrinology and Metabolism, Osaka Red Cross Hospital, Osaka, Japan.
Insights
Hepatitis C-Associated Osteosclerosis (HCAO) involves increased bone density and pain. This case study shows treatment improved bone density and reduced pain in an elderly man with HCAO.
Area of Science:
- Hepatology
- Bone Metabolism
- Rheumatology
Background:
- Hepatitis C-Associated Osteosclerosis (HCAO) is a rare condition characterized by increased bone mass and pain.
- Only eleven cases have been reported since 1992, highlighting its rarity.
Observation:
- This report details a 68-year-old Japanese man with HCAO, followed for three years.
- The patient presented with bone pain and episodic muscular weakness, with a history of blood transfusion and Hepatitis C virus (HCV) seropositivity.
- Initial findings included elevated serum alkaline phosphatase (ALP), slightly decreased calcium, and normal phosphate levels, with radiographic evidence of increasing bone density.
Findings:
- Treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) alleviated bone pain.
- Vitamin D3 and calcium supplementation reduced muscular weakness episodes and normalized serum calcium.
- Over three years, bone mineral density significantly increased, serum ALP normalized, and bone pain decreased, suggesting good skeletal quality.
Implications:
- This case demonstrates effective management strategies for HCAO symptoms.
- The findings suggest that skeletal tissue in HCAO may possess good quality despite increased density.
- Further research into HCAO pathogenesis and long-term outcomes is warranted.
Abstract:
Hepatitis C-Associated Osteosclerosis (HCAO) is characterized by a marked increase in bone mass with deep bone pain. Since 1992, eleven cases of HCAO have been reported. This report describes an elderly Japanese man with HCAO, whose clinical course we followed for 3 years. A 68-year-old man developed pain in both pretibial regions in June 2000, and he had frequent episodic loss of muscular strength in his hands. He had recieved blood transfusion for a bleeding ulcer 43 years before and was seropositive for hepatitis C virus. His serum alkaline phosphatase (ALP) level was markedly increased, while his serum calcium was slightly decreased and serum phosphate was normal. Skeletal radiographs of the lower extremities showed a progressive increase in skeletal density, but did not show any apparent deformity. Administration of nonsteroidal anti-inflammatory drugs led to a reduction in bone pain. Treatment with vitamin D3 and calcium decreased the number of episodes of sudden muscular weakness and maintained serum calcium within the normal range. Three years after the onset of the disease, bone mineral density of his lumbar vertebrae and left hip rose from 0.963 g/cm2 to 1.096 g/cm2, and from 0.938 g/cm2 to 1.383 g/cm2, respectively. His serum ALP level decreased from 2889 to 277 IU/L (normal range: 104-338) and serum calcium normalized. These findings were accompanied by a decrease in bone pain. This case and previous reports suggest that the skeletal tissue of this disease appears to be of good quality.
Related Concept Videos
Hepatitis
Cirrhosis II: Pathophysiology
Viral Hepatitis I: Introduction
Hepatic Encephalopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease II: Clinical Manifestations